Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Gonzalez Cueto D et al. |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. |
1999 |
Acta Gastroenterol. Latinoam. |
pmid:10533659
|
Saito H et al. |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice]. |
1999 |
Kekkaku |
pmid:10535281
|
Gisbert JP et al. |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10540045
|
Hammett DC and Evans MF |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? |
1999 |
Can Fam Physician |
pmid:10540692
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Valencia IC et al. |
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. |
1999 |
Int. J. Dermatol. |
pmid:10561050
|
MartÃn de Argila C and Boixeda D |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection]. |
1999 |
Med Clin (Barc) |
pmid:10562929
|
Adeyemi EO et al. |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10563537
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Mach T and Zahradnik-Bilska J |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. |
1999 |
Prz. Lek. |
pmid:10575912
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
de Luis DA et al. |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. |
1999 |
Clin Nutr |
pmid:10578022
|
Tanigawara Y et al. |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10579481
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Komatsu H et al. |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. |
1999 |
Br. J. Dermatol. |
pmid:10583068
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Franzin L et al. |
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. |
2000 |
Curr. Microbiol. |
pmid:10594221
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Gomollón F et al. |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. |
1999 |
Helicobacter |
pmid:10597390
|
Uygun A et al. |
The effect of Helicobacter pylori eradication on duodenal gastric metaplasia. |
1999 Jul-Aug |
J. Int. Med. Res. |
pmid:10599027
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|
Raderer M et al. |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. |
2000 |
Gut |
pmid:10601069
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Tanaka G et al. |
Effect of clarithromycin on Pseudomonas aeruginosa biofilms. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601796
|
Hamada K et al. |
Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601798
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Suzuki K et al. |
Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages. |
2000 |
FEMS Microbiol. Lett. |
pmid:10612733
|
Giacometti A et al. |
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614961
|
Midolo PD et al. |
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614963
|